LPL Financial
CTXR icon

LPL Financial’s Citius Pharmaceuticals CTXR Stock Holding History

LPL Financial’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.5K Sell
25,045
-22
-0.1% -$18 ﹤0.01% 5867
2025
Q4 		$19.5K Buy
+25,067
New +$31.3K ﹤0.01% 5809
2024
Q4 		– Sell
-459
Closed -$5.75K – 5316
2024
Q3 		$5.75K Sell
459
-2,000
-81% -$33.7K ﹤0.01% 5144
2024
Q2 		$35.9K Buy
2,459
+120
+5% +$2.15K ﹤0.01% 4881
2024
Q1 		$52.5K Buy
2,339
+5
+0.2% +$91 ﹤0.01% 4761
2023
Q4 		$44.1K Buy
+2,334
New +$44.3K ﹤0.01% 4665
2022
Q2 		– Sell
-898
Closed -$40K – 4445
2022
Q1 		$40K Buy
898
+28
+3% +$1.11K ﹤0.01% 4075
2021
Q4 		$33K Buy
870
+4
+0.5% +$181 ﹤0.01% 4262
2021
Q3 		$44K Buy
+866
New +$43.4K ﹤0.01% 4237

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPL Financial's CTXR Position: Q1 2026 in Review

LPL Financial reduced its Citius Pharmaceuticals (CTXR) stake by 0.09% in Q1 2026, selling an estimated $18 and leaving 25,045 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5867.

LPL Financial first reported a position in CTXR in Q3 2021 and has held it in 9 quarters since. The position peaked at $52.5K in Q1 2024. 38 funds tracked by Wall St. Rank hold CTXR as of Q1 2026.

  • LPL Financial held 25,045 shares of Citius Pharmaceuticals worth $22.5K as of Q1 2026.
  • LPL Financial sold 22 Citius Pharmaceuticals shares in Q1 2026, an estimated $18.
  • Citius Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5867 holding.
  • LPL Financial first reported a position in Citius Pharmaceuticals in Q3 2021 and has held it in 9 quarters since.
  • LPL Financial's Citius Pharmaceuticals position peaked at $52.5K in Q1 2024.
  • 38 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.